IntegraGen now offers Fluidigm's IFC technology to French researchers

NewsGuard 100/100 Score

Fluidigm, the inventor of integrated fluidic circuits (IFCs), has joined with IntegraGen SA, one of France’s leading providers of genetic research testing services, to bring IFC technology to French researchers. IntegraGen will offer premium class services to its customers using the Fluidigm BioMark™ System for Genetic Analysis and the Access Array™ sample preparation system for next-generation sequencing. IntegraGen’s lab will also be a demonstration site for researchers investigating Fluidigm’s technology.

“IntegraGen is proud to be able to provide Fluidigm’s technology to its customers. These tools complete the IntegraGen Services portfolio and put our lab at the cutting edge of genotyping and next generation sequencing capabilities”

Fluidigm instrumentation, combined with its microfluidic-based chips, provide high-performance, high throughput gene expression, genotyping, digital PCR, and sample preparation for next-generation sequencing.

“With this wonderful partnership, researchers will be able to immediately utilize IntegraGen’s premiere services based on Fluidigm technology and enjoy the benefits of integrated fluidic circuits. In addition, Fluidigm will have a demonstration site for our European customers to observe and understand our easy workflow and other unique capabilities of our technology,” said Dominique Remy-Renou, Fluidigm's Vice President of European Sales and Support.

“IntegraGen is proud to be able to provide Fluidigm’s technology to its customers. These tools complete the IntegraGen Services portfolio and put our lab at the cutting edge of genotyping and next generation sequencing capabilities,” said Emmanuel Martin, director of genomic services at IntegraGen.

Source:

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
FDA-approved surgical robots trend toward autonomy, study finds